⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for diarrhea

Every month we try and update this database with for diarrhea cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
ScopeGuide-assisted Colonoscopy Versus Conventional ColonoscopyNCT01438645
Colonic Neoplas...
Iron Deficiency...
Diarrhea
Olympus ScopeGu...
18 Years - University of Alberta
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsNCT04038619
Colitis
Diarrhea
Malignant Genit...
Melanoma
Lung Cancer
Ovarian Cancer
Uterine Cancer
Breast Cancer
Cervical Cancer
Fecal Microbiot...
Loperamide
18 Years - M.D. Anderson Cancer Center
Epidemiological Study of Colorectal Cancer in WuHanNCT01863303
Diarrhea
Constipation
Melena
Neoplasm
Colonic Neoplas...
Pain
40 Years - 74 YearsWuhan Pu-Ai Hospital
Epidemiology of Diarrheal Diseases in Pediatric Oncology PatientsNCT02464098
Diarrhea
- 18 YearsSt. Jude Children's Research Hospital
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination ChemotherapyNCT01164215
Colorectal Canc...
Diarrhea
Neutropenia
fluorouracil
leucovorin
oxaliplatin
- UNC Lineberger Comprehensive Cancer Center
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon CancerNCT00006269
Colorectal Canc...
Diarrhea
irinotecan hydr...
octreotide acet...
18 Years - Novartis
A Study of Colesevelam for Lenalidomide-Associated DiarrheaNCT03767257
Multiple Myelom...
Diarrhea
Colesevelam Pil...
18 Years - Memorial Sloan Kettering Cancer Center
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving ChemotherapyNCT00048971
Colorectal Canc...
Diarrhea
Neutropenia
mutation analys...
polymorphic mic...
18 Years - Alliance for Clinical Trials in Oncology
Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal CancerNCT00036517
Colorectal Neop...
Diarrhea
PHY906
18 Years - 75 YearsPhytoCeutica
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer PatientsNCT01523431
Metastatic Colo...
Irinotecan Inje...
5-fluorouracil
Leucovorin
18 Years - The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced DiarrheaNCT01543451
Diarrhea
Elsiglutide
Placebo
18 Years - Helsinn Healthcare SA
Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast CancerNCT06152471
Early-stage Bre...
Diarrhea
Adverse Drug Ev...
SPC-flakes
Salovum
Placebo
18 Years - Uppsala University Hospital
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaNCT00093353
Diarrhea
Drug/Agent Toxi...
Neuroblastoma
cefixime
irinotecan hydr...
temozolomide
1 Year - 30 YearsChildren's Hospital Los Angeles
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelNCT01469338
Diarrhea
Hormone-resista...
Recurrent Prost...
Stage I Prostat...
Stage IIA Prost...
Stage IIB Prost...
Stage III Prost...
Stage IV Prosta...
cabazitaxel
prednisone
octreotide pamo...
questionnaire a...
octreotide acet...
18 Years - University of Southern California
L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer PatientsNCT06019312
Colorectal Canc...
Clostridioides ...
Diarrhea
Sanprobi IBS®
18 Years - 65 YearsMedical University of Gdansk
Prospective Randomized Open Label Study of the Treatment of Therapy-associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium -NCT00444093
Diarrhea
Enteritis
Cancer
Opii normata tr...
Loperamid Treat...
18 Years - Philipps University Marburg Medical Center
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid CancerNCT01739634
Diarrhea
Medullary Thyro...
CASAD
- Salient Pharmaceuticals Incorporated
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid CancerNCT01739634
Diarrhea
Medullary Thyro...
CASAD
- Salient Pharmaceuticals Incorporated
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination ChemotherapyNCT01164215
Colorectal Canc...
Diarrhea
Neutropenia
fluorouracil
leucovorin
oxaliplatin
- UNC Lineberger Comprehensive Cancer Center
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the PelvisNCT00033605
Cervical Cancer
Colorectal Canc...
Diarrhea
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Prostate Cancer
Sarcoma
Unspecified Adu...
Vaginal Cancer
Vulvar Cancer
octreotide acet...
placebo
radiation
18 Years - Alliance for Clinical Trials in Oncology
Prevention of Irinotecan Induced Diarrhea by ProbioticsNCT02819960
Diarrhea
Cancer
Probio-Tec® BG-...
Placebo
18 Years - S&D Pharma SK s.r.o.
A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal CancerNCT00040391
Colorectal Neop...
Diarrhea
Investigational...
Irinotecan
5-fluorouracil
Leucovorin
18 Years - Celgene Corporation
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid SyndromeNCT00774930
Carcinoid Syndr...
Lanreotide
Placebo
18 Years - Ipsen
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary AmyloidosisNCT03499808
Amorphous, Eosi...
Constipation
Diarrhea
Early Satiety
Gastrointestina...
Hepatomegaly
Lymphadenopathy
Macroglossia
Nausea
Primary Systemi...
Purpura
Recurrent Prima...
Refractory Prim...
Isatuximab
Laboratory Biom...
18 Years - SWOG Cancer Research Network
Epidemiological Study of Colorectal Cancer in WuHanNCT01863303
Diarrhea
Constipation
Melena
Neoplasm
Colonic Neoplas...
Pain
40 Years - 74 YearsWuhan Pu-Ai Hospital
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the PelvisNCT00033605
Cervical Cancer
Colorectal Canc...
Diarrhea
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Prostate Cancer
Sarcoma
Unspecified Adu...
Vaginal Cancer
Vulvar Cancer
octreotide acet...
placebo
radiation
18 Years - Alliance for Clinical Trials in Oncology
Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerNCT00084721
Colorectal Canc...
Diarrhea
celecoxib
irinotecan hydr...
18 Years - Roswell Park Cancer Institute
Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced DiarrheaNCT01543451
Diarrhea
Elsiglutide
Placebo
18 Years - Helsinn Healthcare SA
Prospective Randomized Open Label Study of the Treatment of Therapy-associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium -NCT00444093
Diarrhea
Enteritis
Cancer
Opii normata tr...
Loperamid Treat...
18 Years - Philipps University Marburg Medical Center
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.NCT00258401
Cervical Cancer
Diarrhea
Prostate Cancer
Radiation Toxic...
Sarcoma
dietary interve...
management of t...
quality-of-life...
20 Years - 80 YearsCase Comprehensive Cancer Center
Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing ChemotherapyNCT01644097
Diarrhea
Unspecified Adu...
Lactobacillus p...
Lactobacillus a...
placebo
laboratory biom...
questionnaire a...
quality-of-life...
Bifidobacterium...
18 Years - Stanford University
Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase InhibitorsNCT04040712
Diarrhea Caused...
Renal Cell Canc...
Donor FMT
Sham FMT
18 Years - Catholic University of the Sacred Heart
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.NCT00258401
Cervical Cancer
Diarrhea
Prostate Cancer
Radiation Toxic...
Sarcoma
dietary interve...
management of t...
quality-of-life...
20 Years - 80 YearsCase Comprehensive Cancer Center
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon CancerNCT00006269
Colorectal Canc...
Diarrhea
irinotecan hydr...
octreotide acet...
18 Years - Novartis
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal CancerNCT00003057
Colorectal Canc...
Diarrhea
loperamide hydr...
octreotide acet...
18 Years - 120 YearsEastern Cooperative Oncology Group
XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)NCT04926545
Malignant Tumor
Diarrhea
Xiao Chai Hu Ta...
Raloxifene
FOLFIRI regimen
18 Years - 75 YearsGuangzhou University of Traditional Chinese Medicine
Feasibility and Safety of Acupuncture in the Prevention of Late Irinotecan-related Diarrhea in Pediatric PatientsNCT05507736
Pediatric Cance...
Solid Tumor
Acupuncture
0 Years - 18 YearsFundació Sant Joan de Déu
FMT in Checkpoint Inhibitor-mediated Diarrhea and ColitisNCT06206707
Diarrhea
Colitis
Malignant Melan...
Kidney Cancer
Faecal Microbio...
Placebo
18 Years - University of Aarhus
Cyclophosphamide in Treating Young Patients With Severe Autoimmune EnteropathyNCT00258180
Diarrhea
Gastrointestina...
Unspecified Chi...
filgrastim
cyclophosphamid...
1 Year - 21 YearsJohns Hopkins University
Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic RadiationNCT01839721
Cancer
Diarrhea
Abdominal Pain
Quality of Life
Bifilact®
placebo
18 Years - CHU de Quebec-Universite Laval
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell TransplantationNCT01371656
Acute Leukemias...
Bacterial Infec...
Diarrhea
Fungal Infectio...
Musculoskeletal...
Neutropenia
Recurrent Child...
Recurrent Child...
Secondary Acute...
Untreated Child...
levofloxacin
6 Months - 21 YearsChildren's Oncology Group
Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced DiarrheaNCT00582426
Chemotherapy-in...
Octreotide Long...
Standard Treatm...
18 Years - 80 YearsNovartis
A Phase I Dose Escalation Study of Erlotinib in Combination With TheophyllineNCT02080078
Non-small Cell ...
Advanced Solid ...
Theophylline
Erlotinib
18 Years - AHS Cancer Control Alberta
CASAD for Severe Diarrhea in the Emergency DepartmentNCT02018653
Cancer
Diarrhea
Calcium Alumina...
Placebo
Questionnaire
18 Years - M.D. Anderson Cancer Center
The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute FissureNCT05091775
Fissure in Ano
Diarrhea
Asacol is used ...
18 Years - 65 YearsShiraz University of Medical Sciences
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelNCT01469338
Diarrhea
Hormone-resista...
Recurrent Prost...
Stage I Prostat...
Stage IIA Prost...
Stage IIB Prost...
Stage III Prost...
Stage IV Prosta...
cabazitaxel
prednisone
octreotide pamo...
questionnaire a...
octreotide acet...
18 Years - University of Southern California
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelNCT01469338
Diarrhea
Hormone-resista...
Recurrent Prost...
Stage I Prostat...
Stage IIA Prost...
Stage IIB Prost...
Stage III Prost...
Stage IV Prosta...
cabazitaxel
prednisone
octreotide pamo...
questionnaire a...
octreotide acet...
18 Years - University of Southern California
German Colon Capsule RegistryNCT02182466
Colon Cancer
Colon Polyp
Diarrhea
Inflammatory Bo...
Ulcerative Coli...
Colon capsule e...
18 Years - Johann Wolfgang Goethe University Hospital
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid CancerNCT01739634
Diarrhea
Medullary Thyro...
CASAD
- Salient Pharmaceuticals Incorporated
Feasibility and Safety of Acupuncture in the Prevention of Late Irinotecan-related Diarrhea in Pediatric PatientsNCT05507736
Pediatric Cance...
Solid Tumor
Acupuncture
0 Years - 18 YearsFundació Sant Joan de Déu
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation TherapyNCT01198145
Diarrhea
Gastrointestina...
Unspecified Adu...
sulfasalazine
placebo
18 Years - Alliance for Clinical Trials in Oncology
Effect of the Use of Symbiotics in Patients With Colon CancerNCT04874883
Symbiotic
Cancer Colorect...
Cancer Head Nec...
Intestinal Dysb...
Diarrhea
Intestinal Micr...
Nutritional Sta...
Simbyotic
Control Group
18 Years - Federal University of Minas Gerais
The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute FissureNCT05091775
Fissure in Ano
Diarrhea
Asacol is used ...
18 Years - 65 YearsShiraz University of Medical Sciences
Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving IrinotecanNCT00748215
Chemotherapeuti...
Colorectal Canc...
Diarrhea
calcium alumino...
placebo
18 Years - M.D. Anderson Cancer Center
Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat EthylNCT04713202
Neuroendocrine ...
Carcinoid Syndr...
Diarrhea
Telotristat eth...
Peptide Recepto...
Placebo
18 Years - Big Ten Cancer Research Consortium
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal CancerNCT00003057
Colorectal Canc...
Diarrhea
loperamide hydr...
octreotide acet...
18 Years - 120 YearsEastern Cooperative Oncology Group
Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic RadiationNCT01839721
Cancer
Diarrhea
Abdominal Pain
Quality of Life
Bifilact®
placebo
18 Years - CHU de Quebec-Universite Laval
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: